Unicycive Therapeutics In... (UNCY)
0.63
-0.03 (-4.70%)
At close: Jan 15, 2025, 11:43 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -0.7 | -0.45 | -2.91 | -30.4 | -18.28 | -35.46 |
| PS Ratio | 31.54 | 8.55 | n/a | n/a | n/a | n/a |
| PB Ratio | -5.59 | -17.45 | 1.87 | -28.54 | -47.65 | -32.93 |
| P/FCF Ratio | -1.16 | -0.52 | -5.33 | -52.25 | -35.82 | -51.25 |
| P/OCF Ratio | -1.16 | -0.52 | -5.36 | -52.25 | -35.82 | -51.25 |
| OCF/S Ratio | -27.09 | -16.46 | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | -0.21 | -0.33 | 0.02 | -0.94 | -0.52 | -0.87 |
| Quick Ratio | 0.76 | 0.81 | 8.75 | 0.07 | 0.02 | 0.02 |
| Current Ratio | 0.76 | 0.81 | 8.75 | 0.07 | 0.02 | 0.02 |
| Asset Turnover | 0.05 | 0.34 | n/a | n/a | n/a | n/a |
| Interest Coverage | -253.34 | -3.01K | -14.29 | -8.28 | -14.12 | n/a |
| Return on Equity (ROE) | 8.02 | 38.76 | -0.64 | 0.94 | 2.61 | 0.93 |
| Return on Assets (ROA) | -2.15 | -6.41 | -0.57 | -12.29 | -121.26 | -38.62 |
| Return on Capital (ROIC) | 6.21 | 38.74 | -0.54 | 0.76 | 2.22 | 0.79 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 99.26% | n/a | n/a | n/a | n/a |
| Net Profit Margin | -4.53K% | -1.90K% | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -4.53K% | -1.90K% | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -3.08K% | -1.90K% | n/a | n/a | n/a | n/a |
| FCF Margin | -2.71K% | -1.65K% | n/a | n/a | n/a | n/a |
| EBITDA Margin | -4.47K% | -1.90K% | n/a | n/a | n/a | n/a |